Multivalent immunoglobulin-based bioactive assemblies
AssigneeIBC Pharmaceuticals, Inc.
InventorsChien-Hsing Chang, David M. Goldenberg, Edmund A. Rossi
Life of this patent
Estimating the term…
Loading patent…
AssigneeIBC Pharmaceuticals, Inc.
InventorsChien-Hsing Chang, David M. Goldenberg, Edmund A. Rossi
Estimating the term…
The present invention concerns methods and compositions for stably tethered structures of defined compositions, which may have multiple functionalities and/or binding specificities. Preferred embodiments concern hexameric stably tethered structures comprising one or more IgG antibody fragments and which may be monospecific or bispecific. The disclosed methods and compositions provide a facile and general way to obtain stably tethered structures of virtually any functionality and/or binding specificity. The stably tethered structures may be administered to subjects for diagnostic and/or therapeutic use, for example for treatment of cancer or autoimmune disease. The stably tethered structures may bind to and/or be conjugated to a variety of known effectors, such as drugs, enzymes, radionuclides, therapeutic agents and/or diagnostic agents.
A hexameric stably tethered structure comprising an IgG antibody attached to two AD2 moieties of SEQ ID NO:
A hexameric stably tethered structure comprising an JgG antibody attached at its C-terminal end to two AD2 moieties of SEQ ID NO:
Dependencies are inferred from the claim text.